| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 74 | 78 | PF00656 | 0.342 |
| CLV_C14_Caspase3-7 | 80 | 84 | PF00656 | 0.299 |
| CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.447 |
| CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.482 |
| CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.447 |
| CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.482 |
| DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.445 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.358 |
| LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.358 |
| LIG_FHA_2 | 72 | 78 | PF00498 | 0.310 |
| LIG_FHA_2 | 87 | 93 | PF00498 | 0.472 |
| LIG_LIR_Gen_1 | 71 | 81 | PF02991 | 0.275 |
| LIG_LIR_Nem_3 | 71 | 76 | PF02991 | 0.352 |
| LIG_Pex14_2 | 5 | 9 | PF04695 | 0.367 |
| LIG_REV1ctd_RIR_1 | 3 | 12 | PF16727 | 0.353 |
| LIG_SH2_CRK | 26 | 30 | PF00017 | 0.405 |
| LIG_SH2_CRK | 54 | 58 | PF00017 | 0.287 |
| LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.343 |
| MOD_CDK_SPxxK_3 | 86 | 93 | PF00069 | 0.439 |
| MOD_CK1_1 | 71 | 77 | PF00069 | 0.304 |
| MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.476 |
| MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.477 |
| MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.422 |
| MOD_N-GLC_1 | 14 | 19 | PF02516 | 0.379 |
| MOD_N-GLC_1 | 71 | 76 | PF02516 | 0.257 |
| MOD_NEK2_1 | 97 | 102 | PF00069 | 0.563 |
| MOD_OFUCOSY | 61 | 66 | PF10250 | 0.264 |
| MOD_Plk_1 | 14 | 20 | PF00069 | 0.415 |
| MOD_Plk_1 | 71 | 77 | PF00069 | 0.263 |
| MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.441 |
| MOD_SUMO_rev_2 | 77 | 86 | PF00179 | 0.393 |
| TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.414 |
| TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.443 |
| TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.298 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HU10 | Leptomonas seymouri | 82% | 100% |
| A0A1X0P7S7 | Trypanosomatidae | 63% | 88% |
| A0A3R7KLJ1 | Trypanosoma rangeli | 62% | 92% |
| A0A3S5H726 | Leishmania donovani | 85% | 100% |
| A4HXQ7 | Leishmania infantum | 87% | 100% |
| B6DTF0 | Bodo saltans | 50% | 84% |
| D0A037 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 90% |
| E9ARG8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
| Q4QE11 | Leishmania major | 88% | 100% |